Have you heard? ACC Committee applications are open! Visit the portal to review the 300➕ leadership roles across more than 80 ACC Committees.
✔️ #ACCFIT Section Leadership Council
✔️ #NCDR
✔️ #ACCAccreditation
✔️ More!
Find your fit and apply by Sept. 4 ➡️ https://bit.ly/3HrKw6B #ACCLeadership
Great study reviews by @erictopol.bsky.social
Another great session treating #cardiovasculardisease #diabetes. If you missed it, be sure to watch on demand. Excellent session with real world application. @accintouch.bsky.social #ACC.25
The STRIDE trial demonstrated that semaglutide significantly improves function, symptoms, and health-related QoL in patients with symptomatic #cvPAD and T2DM.
Get the full clinical trial details here ➡️ bit.ly/42dnA1n #ACC25 #CardioSky #MedSky
Amazing leaders in innovation on one stage @accintouch.bsky.social #ACC.25
The use of an SGLT2 inhibitor drug improved outcomes in patients undergoing TAVI (transcatheter aortic valve implantation). A randomized, placebo-controilled trial of 620 patients with high risk
www.nejm.org/doi/full/10....
#ACC25 @nejm.org
Extended anticoagulant therapy with reduced-dose apixaban was noninferior to full-dose in patients with active cancer and #cvVTE, based on findings from the API-CAT trial presented at #ACC25.
Read the journal scan to learn more: bit.ly/43w2A8v
#CardioSky #MedSky
Let’s light up #CardioSky with all the bright lights of cardiology!
@vietheartpa.bsky.social @debdnp.bsky.social @brototod.bsky.social @drmarthagulati.bsky.social
@andreaprice-317.bsky.social @a-l-bailey.bsky.social
DOACs significantly lower ischaemic stroke risk in atrial fibrillation patients post-intracerebral haemorrhage, but increase bleeding risk.
by Veltkamp R, Korompoki E (...) Heuschmann PU et 48 al. in Lancet #MedSky
📖 read the article: linkinghub.elsevier.com/retrieve/pii/S0140673625...
As someone who cares for #rural #underserved the challenges are real. Limited #access long waits for specialty care.2 hour or longer drive #Familytraditions #diet #lackofexercise #tobacco #vape. Thanks @jaccjournals.bsky.social for illuminating issues #cardiosky @accintouch.bsky.social #ACCCVT
Great read and reminder
3/4 PulseCheck Podcast #Palliative Cardiology series - #ACCGeriatric collab with #ACCCVT and the 🤩@andreaprice-317.bsky.social
High Risk Procedures in Our High Risk Patients
@christycantey.bsky.social Gwen Bernacki and Rich Josephson - so much wisdom here!
www.acc.org/latest-in-ca...
#tirzepatide #OSA #CardioSky
www.empr.com/news/zepboun...
Managing GLP-1 RA GI-related adverse effects - Common question, new review. Some new tips for your patients. #diabetes, #obesity, #GLP-1RA
www.dovepress.com/dietary-reco...
Well deserved Congratulations @garimasharmamd.bsky.social
You all will have to visit me. See you in Chicago
Enjoying the warmth of a fire on a cold WV night
#CardioSky peeps: @worldheart.org is now where the skies are blue!
Follow them for a global perspective on advocacy!
Appalachian sunrises and sunsets. I am so lucky to call it home.
Another peer reviewed journal joining #CardioSky @jaepattonnp.bsky.social @vietheartpa.bsky.social @beaverspharmd.bsky.social
Working with underserved I am not surprised. They choose what they can afford. I have elderly husband/wives with high copays on SGL2 & NOAC they cut meds in 1/2 & or share meds.
My visitors today. Ironic they showed up after #Thanksgiving They are safe with me, I counted 10 wild turkeys #plantbaseddiet #AlmostHeaven
We used to hear the term "tired blood." [Geritol]
Now it's tired proteins. Proteolethargy. Reduced protein mobility as an underpinning for chronic diseases
www.cell.com/cell/abstrac...
Congratulations! Happy to have great physicians #UVA in cardiology I rest easy knowing my patients have the best care!
Another negative study about #vitD supplements in older adults, by @spjuraschek.bsky.social & colleagues from the STURDY trial. #CardioSky
MEGA PDF on Incretin therapies by the one and only @drkevinfernando.bsky.social
Very topical at the moment for CRM world
#PharmSky #Medsky #GPsky #CRM #CardioSky
img.medscapestatic.com/vim/live/pro...
So exciting! #SUMMIT trial, the first #HFpEF trial of incretin therapy with HF clinical outcomes as prespecified primary outcome. And #tirzepatide reduced CV death or worsening HF by significant 38%! Improvement in KCCQ quality of life by 7 pts, wt loss 12%, hsCRP reduction by 35%! #AHA24 #CardioSky
Don't forget to register for the #ACC.25 Scientific Sessions in Chicago! Today is the last day for early bird registration @vietheartpa.bsky.social @jaepattonnp.bsky.social @erinmichos.bsky.social
Deleted my X Account hoping to find my cardiology friends to follow. I miss the education on the other platform. Looking forward to building the links on this site.
